Dr. Lal Path Labs Ltd. has informed the Exchange regarding Grant of 168500 Options.
LALPATHLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Dr. Lal Path Labs has informed the stock exchanges that its Nomination & Remuneration Committee approved the grant of 1,68,500 stock options to eligible employees on April 9, 2025. These options are being issued under the company's Employee Stock Option Plan 2022 (ESOP 2022), with each option convertible into one equity share of Rs. 10 face value. The exercise price will be set by the Committee at the time of each grant, with the flexibility to offer up to a 10% discount to the prevailing market price. Options will vest over a period of not less than 1 year and not more than 4 years from the grant date, and must be exercised within 5 years of vesting. As of now, no options have been vested, exercised, or lapsed.
This is a routine ESOP allotment disclosure and signals the company is using stock-based incentives to retain and motivate employees. The 1,68,500 shares represent a small dilution relative to the company's overall share base, so the immediate impact on existing shareholders is limited. However, if all options are eventually exercised, it will lead to some equity dilution.